NASDAQ:TALS
Delisted

Talaris Therapeutics Stock Signals

etoro logo Buy TALS
*Your capital is at risk
$2.72
+0 (+0%)
At Close: Dec 14, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Talaris Therapeutics, Inc.

General

Signal Type Signal Value Data
Score 0.000 38 days ( 0 %
Last Price $2.72 0 %
Performance History
7 Days
$2.72 $2.72
0%
30 Days
$2.72 $2.72
0%
12 Mos
$1.29 $2.72
110.85%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $2.72 - $2.72
Trend - 3 mos -3.74 % High Width: 17.15 %
Pred. range - 3 mos $2.40 - $2.81 Low -11.66 % - 3.49 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Oct 19, 2023 - 40 days
RSI Short Pivot Signal Buy Very Low Nov 02, 2023 - 30 days
Short MA 3 mos Sell Low Oct 17, 2023 - 42 days
Long MA 3 mos Sell Medium Oct 17, 2023 - 42 days
Short/Long MA 3 mos Sell Medium Oct 24, 2023 - 37 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 42.91
Signal Type Signal Value Importance Data
Trend - 12 mos 72.27 % Very High Width: 56.51 %
Pred. range - 12 mos $4.43 - $6.93 High 62.79 % - 154.78 %
Short MA 12 mos Sell Very High Oct 17, 2023 - 42 days
Long MA 12 mos Sell Very High Oct 16, 2023 - 43 days
Short/Long MA 12 mos Sell Very High Sep 18, 2023 - 63 days
Pivot Long Buy Low Oct 19, 2023 - 40 days
RSI Long Pivot Signal Buy Low Nov 13, 2023 - 23 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT TALARIS THERAPEUTICS, INC.
Talaris Therapeutics
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and metabolic disorders. Its lead product candidate is FCR001, a novel allogeneic cell therapy that is in...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE